What is the market cap of Haleos Labs Limited?

As of 27/05/2026, the market cap of Haleos Labs Limited stands at ₹493.20 Cr.

What is the PE and PB ratio of Haleos Labs Limited?

The PE and PB ratios of Haleos Labs Limited is 27.31 ratio and 684.26 ratio as of 27/05/2026.

What is the 52 week high and low of Haleos Labs Limited?

The 52 week high and low of Haleos Labs Limited is ₹1774 and ₹1067 as of 27/05/2026.

How can I buy Haleos Labs Limited share?

You can easily buy Haleos Labs Limited shares on the Bajaj Broking platform by opening a Demat account and verifying your KYC documents online. There are no account opening charges for a Demat account with Bajaj Broking.

What determines a company’s share price?

A company’s share price is determined by supply and demand dynamics in the stock market. Factors influencing it include the company’s financial performance, earnings growth, revenue, and profitability, as well as broader economic conditions, market sentiment, and investor perception. Other determinants include sector trends, government policies, interest rates, and global events. Positive news or growth prospects can drive demand and raise the share price, while negative developments can push it lower. Analysts’ recommendations, institutional buying or selling, and technical factors such as trading volume also influence price movements. Ultimately, the share price reflects the market’s collective view of a company’s current and future value.

What is the “last sale,” “bid,” and “ask” price of Haleos Labs Limited?

The “last sale” is the most recent price at which a stock, like Haleos Labs Limited , was traded. The “bid” price represents the highest price buyers are willing to pay, while the “ask” price is the lowest price sellers are ready to accept. The difference between the bid and ask is known as the spread. Monitoring these prices helps investors understand market sentiment and liquidity. For example, a narrow spread indicates high liquidity and active trading, while a wide spread may suggest lower activity or higher volatility. These metrics are crucial for executing timely buy or sell orders in the stock market.

How to read share price charts for Haleos Labs Limited?

Share price charts display the historical price movement of Haleos Labs Limited , helping investors analyse trends, patterns, and potential entry or exit points. Charts typically show candlestick patterns, line graphs, or bar charts, representing open, high, low, and close prices. Key indicators include moving averages, support and resistance levels, and trading volume. Candlestick patterns can reveal bullish or bearish trends, while volume confirms the strength of price movements. Investors can use charts for technical analysis to assess momentum, predict short-term fluctuations, or complement fundamental analysis for long-term decisions. Understanding trends over daily, weekly, or monthly periods helps in making informed trading and investment choices.

What is volatility, and how does it affect share price movement for Haleos Labs Limited?

Volatility measures the degree of price fluctuations of a stock over time. High volatility indicates that Haleos Labs Limited share price can experience large swings in short periods, while low volatility suggests stable prices. Factors causing volatility include market sentiment, earnings announcements, global events, economic indicators, and industry news. High volatility can create opportunities for traders to profit from rapid price changes but also increases risk for long-term investors. Understanding volatility helps investors manage risk, set stop-loss limits, and determine the appropriate investment horizon based on their risk tolerance.

HALEOS LABS LIMITED

HALEOSLABS

Small Cap | Pharmaceuticals

₹1625

-34.69 (-2.09%)

‌

Stock price as on 27 May 2026 at 15:29 PM

Haleos labs limited share price update

As of the latest trading session, Haleos Labs Limited share price is currently at ₹1625, which is down by ₹-34.69 from its previous closing. Today the...

Haleos Labs Limited stock performance

Today’s low

₹1,616.7

Today’s high

₹1,667

₹1,625

52 week low

₹1,067

52 week high

₹1,774

₹1,625

Open

₹1,667.00

Previous close

₹1,659.70

Share volume

1,054

Total traded value (Lakh)

₹17.19

Upper circuit

₹1,825.60

Lower circuit

₹1,493.80

Haleos Labs Limited fundamentals

Market cap (Cr)

₹493.20

P/E ratio (TTM)

27.31

Book value per share

₹684.26

Beta

0.38

Return on equity

11.45%

Earnings per share (TTM)

₹60.26

Dividend yield

0.09%

Net profit/quarter (Cr)

₹5.41

Haleos Labs Limited financials

(Values in Cr)

Revenue

Net income

Particulars	Dec 25 (₹ value in crores)
Revenue	₹80.72
Operating expense	₹73.30
Net income	₹5.41
Net profit margin	6.7%
Earning per share	₹17.88
EBITDA	₹11.63
Effective tax rate	27.77%

Particulars	Sep 25 (₹ value in crores)
Revenue	₹77.84
Operating expense	₹71.24
Net income	₹4.98
Net profit margin	6.39%
Earning per share	₹16.46
EBITDA	₹11.24
Effective tax rate	29.36%

Particulars	Jun 25 (₹ value in crores)
Revenue	₹79.04
Operating expense	₹72.57
Net income	₹5.16
Net profit margin	6.52%
Earning per share	₹17.06
EBITDA	₹11.84
Effective tax rate	31.01%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹85.43
Operating expense	₹84.29
Net income	₹2.68
Net profit margin	3.13%
Earning per share	₹8.85
EBITDA	₹7.79
Effective tax rate	19.81%

Particulars	Dec 24 (₹ value in crores)
Revenue	₹82.88
Operating expense	₹74.33
Net income	₹6.23
Net profit margin	7.51%
Earning per share	₹20.60
EBITDA	₹13.13
Effective tax rate	27.64%

Particulars	Mar 25 (₹ value in crores)
Revenue	₹333.37
Operating expense	₹307.27
Net income	₹21.37
Net profit margin	6.41%
Earning per share	₹70.69
EBITDA	₹48.18
Effective tax rate	28.86%

Particulars	Mar 24 (₹ value in crores)
Revenue	₹300.00
Operating expense	₹284.71
Net income	₹13.07
Net profit margin	4.35%
Earning per share	₹43.22
EBITDA	₹38.26
Effective tax rate	31.65%

Particulars	Mar 23 (₹ value in crores)
Revenue	₹315.24
Operating expense	₹302.09
Net income	₹13.22
Net profit margin	4.19%
Earning per share	₹43.72
EBITDA	₹31.63
Effective tax rate	28.03%

Particulars	Mar 22 (₹ value in crores)
Revenue	₹345.63
Operating expense	₹326.88
Net income	₹25.38
Net profit margin	7.34%
Earning per share	₹83.95
EBITDA	₹45.60
Effective tax rate	23.04%

Particulars	Mar 21 (₹ value in crores)
Revenue	₹260.26
Operating expense	₹242.23
Net income	₹13.17
Net profit margin	5.06%
Earning per share	₹43.56
EBITDA	₹31.06
Effective tax rate	31.98%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹650.15
Return on Equity (ROE)	10.03%
Return on Capital Employed (ROCE)	12.26%
Total debt to equity ratio	0.5
EBITDA margin	12.94%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹584.84
Return on Equity (ROE)	3.67%
Return on Capital Employed (ROCE)	7.24%
Total debt to equity ratio	0.58
EBITDA margin	10.34%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹557.71
Return on Equity (ROE)	6.12%
Return on Capital Employed (ROCE)	8.31%
Total debt to equity ratio	0.56
EBITDA margin	8.91%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹503.53
Return on Equity (ROE)	11.26%
Return on Capital Employed (ROCE)	11.95%
Total debt to equity ratio	0.51
EBITDA margin	9.31%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹427.40
Return on Equity (ROE)	11.07%
Return on Capital Employed (ROCE)	12.53%
Total debt to equity ratio	0.53
EBITDA margin	10.85%

Particulars (annual)	Mar 25 (₹ value in crores)
Book value per share	₹652.19
Return on Equity (ROE)	11.45%
Return on Capital Employed (ROCE)	13.69%
Total debt to equity ratio	0.46
EBITDA margin	13.1%

Particulars (annual)	Mar 24 (₹ value in crores)
Book value per share	₹582.90
Return on Equity (ROE)	7.68%
Return on Capital Employed (ROCE)	10.68%
Total debt to equity ratio	0.53
EBITDA margin	11.67%

Particulars (annual)	Mar 23 (₹ value in crores)
Book value per share	₹542.55
Return on Equity (ROE)	7.2%
Return on Capital Employed (ROCE)	8.85%
Total debt to equity ratio	0.47
EBITDA margin	8.25%

Particulars (annual)	Mar 22 (₹ value in crores)
Book value per share	₹500.16
Return on Equity (ROE)	11.47%
Return on Capital Employed (ROCE)	12.54%
Total debt to equity ratio	0.39
EBITDA margin	8.67%

Particulars (annual)	Mar 21 (₹ value in crores)
Book value per share	₹417.88
Return on Equity (ROE)	10.99%
Return on Capital Employed (ROCE)	13.83%
Total debt to equity ratio	0.4
EBITDA margin	10.85%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹1.50
Total assets	₹389.99
Total liabilities	₹389.99
Total equity	₹212.04
Shares outstanding	₹0.30
Price to book ratio	₹1.66
Return on assets (%)	5.15%
Return on capital	6.79%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹1.49
Total assets	₹391.32
Total liabilities	₹391.32
Total equity	₹193.63
Shares outstanding	₹0.30
Price to book ratio	₹1.16
Return on assets (%)	2.32%
Return on capital	3.12%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹4.41
Total assets	₹394.89
Total liabilities	₹394.89
Total equity	₹188.21
Shares outstanding	₹0.30
Price to book ratio	₹0.96
Return on assets (%)	2.9%
Return on capital	4%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹4.39
Total assets	₹356.74
Total liabilities	₹356.74
Total equity	₹164.92
Shares outstanding	₹0.30
Price to book ratio	₹1.39
Return on assets (%)	7.09%
Return on capital	10.46%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹11.06
Total assets	₹302.29
Total liabilities	₹302.29
Total equity	₹129.21
Shares outstanding	₹0.30
Price to book ratio	₹1.18
Return on assets (%)	4.48%
Return on capital	7.01%

Particulars	Mar 25 (₹ value in crores)
Cash and short term investments	₹1.40
Total assets	₹358.31
Total liabilities	₹358.31
Total equity	₹197.17
Shares outstanding	₹0.30
Price to book ratio	₹1.66
Return on assets (%)	5.96%
Return on capital	7.73%

Particulars	Mar 24 (₹ value in crores)
Cash and short term investments	₹1.25
Total assets	₹348.23
Total liabilities	₹348.23
Total equity	₹176.22
Shares outstanding	₹0.30
Price to book ratio	₹1.16
Return on assets (%)	3.75%
Return on capital	4.93%

Particulars	Mar 23 (₹ value in crores)
Cash and short term investments	₹0.95
Total assets	₹337.38
Total liabilities	₹337.38
Total equity	₹164.02
Shares outstanding	₹0.30
Price to book ratio	₹0.96
Return on assets (%)	3.91%
Return on capital	5.3%

Particulars	Mar 22 (₹ value in crores)
Cash and short term investments	₹2.13
Total assets	₹312.00
Total liabilities	₹312.00
Total equity	₹151.21
Shares outstanding	₹0.30
Price to book ratio	₹1.39
Return on assets (%)	8.13%
Return on capital	12.03%

Particulars	Mar 21 (₹ value in crores)
Cash and short term investments	₹8.90
Total assets	₹271.74
Total liabilities	₹271.74
Total equity	₹126.33
Shares outstanding	₹0.30
Price to book ratio	₹1.18
Return on assets (%)	4.84%
Return on capital	7.71%

Particulars	Mar 25 (₹ value in crores)
Net income	₹26.18
Cash from operations	₹42.55
Cash from investing	-₹14.99
Cash from financing	-₹19.12
Net change in cash	-₹0.06
Free cash flow	₹57.90

Particulars	Mar 24 (₹ value in crores)
Net income	₹9.84
Cash from operations	₹27.30
Cash from investing	-₹18.45
Cash from financing	-₹6.56
Net change in cash	-₹0.70
Free cash flow	₹48.17

Particulars	Mar 23 (₹ value in crores)
Net income	₹14.24
Cash from operations	₹17.95
Cash from investing	-₹31.29
Cash from financing	₹16.88
Net change in cash	₹0.29
Free cash flow	₹66.50

Particulars	Mar 22 (₹ value in crores)
Net income	₹20.03
Cash from operations	-₹3.53
Cash from investing	-₹7.14
Cash from financing	₹10.83
Net change in cash	-₹7.55
Free cash flow	₹47.61

Particulars	Mar 21 (₹ value in crores)
Net income	₹19.56
Cash from operations	₹40.10
Cash from investing	-₹26.23
Cash from financing	-₹2.54
Net change in cash	₹6.38
Free cash flow	₹75.66

Particulars	Mar 25 (₹ value in crores)
Net income	₹30.04
Cash from operations	₹36.53
Cash from investing	-₹13.76
Cash from financing	-₹14.20
Net change in cash	₹0.06
Free cash flow	₹50.61

Particulars	Mar 24 (₹ value in crores)
Net income	₹19.11
Cash from operations	₹17.75
Cash from investing	-₹13.74
Cash from financing	-₹0.81
Net change in cash	₹0.18
Free cash flow	₹31.47

Particulars	Mar 23 (₹ value in crores)
Net income	₹16.02
Cash from operations	₹8.07
Cash from investing	-₹27.96
Cash from financing	₹22.59
Net change in cash	-₹0.79
Free cash flow	₹41.98

Particulars	Mar 22 (₹ value in crores)
Net income	₹20.28
Cash from operations	-₹7.09
Cash from investing	-₹7.48
Cash from financing	₹14.62
Net change in cash	-₹7.51
Free cash flow	₹17.86

Particulars	Mar 21 (₹ value in crores)
Net income	₹19.35
Cash from operations	₹26.22
Cash from investing	-₹5.94
Cash from financing	-₹7.86
Net change in cash	₹7.80
Free cash flow	₹39.54

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENT L	₹32.40	13.39	1.56	₹248.29	₹23.12 / ₹40.00
BLISS GVS PHARMA LTD.	₹381.10	30.83	3.37	₹4,031.62	₹118.35 / ₹381.10
CIPLA LTD	₹1,417.05	28.06	3.32	₹1,14,469.38	₹1,165.55 / ₹1,672.20
FERMENTA BIOTECH LIMITED	₹290.60	9.67	2.18	₹855.26	₹256.40 / ₹399.00

Company name	Price	P/E	P/B	Market cap	52 week low/high
AMBALAL SARABHAI ENT L	₹32.40	13.39	1.56	₹248.29	₹23.12 / ₹40.00
BLISS GVS PHARMA LTD.	₹381.10	30.83	3.37	₹4,031.62	₹118.35 / ₹381.10
CIPLA LTD	₹1,417.05	28.06	3.32	₹1,14,469.38	₹1,165.55 / ₹1,672.20
FERMENTA BIOTECH LIMITED	₹290.60	9.67	2.18	₹855.26	₹256.40 / ₹399.00

Haleos Labs Limited technical summary

₹1631.5

-1.69 ▼

Bearish

Bullish

5 Day1,646.8

10 Day1,621.9

12 Day1,611.5

20 Day1,568.1

26 Day1,538.8

50 Day1,456.2

100 Day1,377.4

200 Day1,312.8

Investment Returns

Over 1 Month21.96%▲

Over 3 Months26.45%▲

Over 6 Months21.89%▲

Over 1 Year22.02%▲

Haleos Labs Limited Shareholding pattern

Public

27.59%

Promoter holdings

72.1%

FII

DII

0.29%

Promoter shares

Promoter shares	Share	Category
Annapurna Talluri	7,42,436 (24.56%)	Shareholding of Promoter and Promoter Group
Tvvsn Murthy	4,80,034 (15.88%)	Shareholding of Promoter and Promoter Group
Venkata Praveen Talluri	2,73,939 (9.06%)	Shareholding of Promoter and Promoter Group
Ramesh Babu Potluri	2,40,190 (7.94%)	Shareholding of Promoter and Promoter Group
Sudeepthi Gopineedi	1,99,494 (6.6%)	Shareholding of Promoter and Promoter Group

About HALEOS LABS LIMITED

SMS Lifesciences India Limited was incorporated originally as 'Potluri Real Estate Private Limited' on May 31, 2006. The Company's name was changed to 'Potluri Packaging Industries Private Limited' on 6 November, 2013 and again changed to 'SMS Lifesciences India Private Limited on 4 August, 2014 to undertake the activities related pharma sector. The Company became a wholly owned subsidiary Company of SMS Pharmaceuticals Limited w.e.f. 01.04.2016 and subsequently got converted into a Public Limited w.e.f. 22 June, 2016. The Company is engaged in the business of manufacturing and export of Active Pharma Ingredients(APIs) and their intermediates. The Company is having manufacturing facilities at Kazipally and Jeedimetla, Hyderabad with an installed capacity of 65 KL. What started off as a single facility - single product manufacturing company in 1990 grew to be a multi-location group having products spread across an array of therapeutic segments. SMS Group was given the export house status in the year 1997-98. Having three multi product facilities in operation and a research centre, the Company executed contract manufacturing and research assignment for global customer base. The Scheme of Arrangement between SMS Pharmaceuticals Limited with the Company was implemented in 2016-17. Pursuant to the Scheme, the Semi Regulated facilities i.e Unit No. I, IV and V along with premises situated at Industrial Estate, Sanathnagar, Hyderabad; Industrial Development Area, Jeedimetla, Hyderabad; Premises bearing Flat No.417, Nilgiri, Aditya Enclave, Ameerpet, Hyderabad; vacant land admeasuring Ac 19.00 cents situated at Pharma City, Parawada, Visakhapatnam and Investments relating to Semi Regulated Units of SMS Pharmaceuticals Limited got demerged into the Company and the said Scheme of Demerger was given effect on May 17, 2017. The Company allotted 30,23,287 Equity Shares of Rs. 10 each to the shareholders of SMS Pharmaceuticals Limited on 27 June, 2017 in pursuance of Demerger Scheme. The Company made Mahi Drugs Private Limited as a wholly owned subsidiary of the Company in 2017-18. by acquiring 9,00,000 Equity Shares effective on 17th September, 2018. Similarly, the Company diluted its 10% stake in Mahi Drugs Private Limited during the period 2021-22 and it ceased to be a wholly-owned subsidiary of the Company w.e.f. 7th February, 2022. Company completed two regulatory inspections by the US Food and Drug Administration (USFDA). Company's Unit 1 at Kazipally, Hyderabad underwent USFDA inspection in May, 2025, resulting in a successful outcome with a Voluntary Action Indicated (VAI) status. Additionally, the Company's subsidiary, Mahi Drugs also successfully completed its USFDA inspection in February, 2025 of its manufacturing facility located in Vizag, Andhra Pradesh. Company expanded the new API production line, which is expected to become operational in the latter half of the year 2025-26.

Parent Organisation

Indian Private

NSE Symbol

HALEOSLABS

Founded

2006

HALEOS LABS LIMITED CORPORATE ACTION

Dividend date	Dividend amount	Dividend type	Record date	Instrument type
24 Sept 2025	1.5	Final	24 Sept 2025	Equity shares
23 Sept 2024	1.5	Final	23 Sept 2024	Equity shares
22 Sept 2023	1.5	Final	23 Sept 2023	Equity shares
22 Sept 2022	1.5	Final	24 Sept 2022	Equity shares
20 Sept 2021	1.5	Final	21 Sept 2021	Equity shares
19 Sept 2019	1.5	Final	23 Sept 2019	Equity shares

View more stocks

sun pharmaceutical ind l

₹1,844.3

▲ 0.19%

divi s laboratories ltd

₹6,797.5

▲ 0.65%

torrent pharmaceuticals ltd.

₹4,537.8

▲ 1.92%

cipla ltd

₹1,418.2

▲ 0.04%

dr. reddy s laboratories

₹1,319

▼ 0.67%

zydus lifesciences limited

₹1,085.8

▲ 0.62%

lupin limited

₹2,276.4

▲ 0.45%

What’s trending

All stocks

VPAL

VEGORAMA PUNJABI ANGITHI LIMIT

124

+47 (+61.04%)

TRIOMERC

TRIO MERCANTILE & TRADING LTD.

1.26

+0.21 (+20%)

SURYALA

SURYALATA SPINNING MILL L

ALKALI METALS LTD

Top gainers

HINDALCO

HINDALCO INDUSTRIES LTD

1149.7

+45.90 (+4.16%)

TMPV

TATA MOTORS PASS VEH LTD

400.95

+15.35 (+3.98%)

POWERGRID

POWER GRID CORP. LTD.

ETERNAL LIMITED

Top losers

ONGC

OIL AND NATURAL GAS CORP.

ITC LTD

HDFC BANK LTD

HDFC LIFE INS CO LTD

Frequently asked questions

 As of 27/05/2026, at 15:29 PM, the Haleos Labs Limited share price stands at ₹1625.

Related tags

Disclaimer

*Disclaimer for Bajaj Finance Limited (‘BFL’):

Stock trading business is carried by Bajaj Financial Securities Limited ("BFSL"), a broker and Depository Participant registered with Securities Exchange Board of India and offers various products/services related to Securities market (Securities market products/services). BFL merely facilitates display of data shared by BFSL on its webpage/mobile application. Such data received from BFSL, or any of its service providers is on “as is” basis. BFL does not make any representation or warranty, express or implied, regarding accuracy, completeness of such data displayed herein.

When you opt to avail the Securities market products/services of BFSL by clicking on the BFSL weblink/mobile app, you will be redirected to BFSL's web page/mobile app for initiation and completion of the transaction. You are supposed to exercise independent diligence by reading all the related documents carefully before deciding to invest in Securities market Products/services.

BFL is a Non-Banking Financial Company carrying the business of acceptance of deposits and providing lending solutions to Retail and Corporate customers. BFL does not offer nor advice on Securities market products/services and shall not be liable or responsible for any of your investment decision."

**Disclaimer: For Bajaj Financial Securities Limited

Investments in the securities market are subject to market risk, read all related documents carefully before investing.

Broking services offered by Bajaj Financial Securities Limited (Bajaj Broking). Reg Office: Bajaj Auto Limited Complex, Mumbai –Pune Road Akurdi Pune 411035. Corporate Office: Bajaj Financial Securities Limited, 1st Floor, Mantri IT Park, Tower B, Unit No 9 & 10, Viman Nagar, Pune, Maharashtra 411014. SEBI Registration No.: INZ000218931 | BSE Cash/F&O/CDS (Member ID:6706) | NSE Cash/F&O/CDS (Member ID: 90177) | DP registration No: IN-DP-418-2019 | CDSL DP No.: 12088600 | NSDL DP No. IN304300 | AMFI Registration No.: ARN –163403.

Details of Compliance Officer: Mr. Boudhayan Ghosh (For Broking/DP/Research) | Email: compliance_sec@bajajbroking.in | Contact No.: 020-4857 4486. For any investor grievances write to compliance_sec@bajajbroking.in/ compliance_dp@bajajbroking.in (DP related)

This content is for educational purpose only. Securities quoted are exemplary and not recommendatory.

Research Services are offered by Bajaj Broking as Research Analyst under SEBI Regn: INH000010043.

For more disclaimer, check here: https://www.bajajbroking.in/disclaimer

HALEOS LABS LIMITED

Haleos labs limited share price update

Haleos Labs Limited stock performance

₹1,616.7

₹1,667

₹1,067

₹1,774

Haleos Labs Limited fundamentals

Haleos Labs Limited financials

Particulars

Dec 25 (₹ value in crores)

Revenue

₹80.72

Operating expense

₹73.30

Net income

₹5.41

Net profit margin

6.7%

Earning per share

₹17.88

EBITDA

₹11.63

Effective tax rate

27.77%

Particulars

Sep 25 (₹ value in crores)

Revenue

₹77.84

Operating expense

₹71.24

Net income

₹4.98

Net profit margin

6.39%

Earning per share

₹16.46

EBITDA

₹11.24

Effective tax rate

29.36%

Particulars

Jun 25 (₹ value in crores)

Revenue

₹79.04

Operating expense

₹72.57

Net income

₹5.16

Net profit margin

6.52%

Earning per share

₹17.06

EBITDA

₹11.84

Effective tax rate

31.01%

Particulars

Mar 25 (₹ value in crores)

Revenue

₹85.43

Operating expense

₹84.29

Net income

₹2.68

Net profit margin

3.13%

Earning per share

₹8.85

EBITDA

₹7.79

Effective tax rate

19.81%

Particulars

Dec 24 (₹ value in crores)

Revenue

₹82.88

Operating expense

₹74.33

Net income